We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Compass ...

Sequoia Financial Advisors LLC bought a new stake in Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the ...

Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a company If you want to know who really controls Compass Therapeutics, Inc.

XRP News Today: Market Eyes SEC’s Next Move Amid Appeal Speculation; Tariffs Drop BTCFri, 14 Mar 2025 02:28:38 GMT Japanese Yen and Aussie Dollar News: Wage Hikes Could Corner BoJ Into Policy ...

In this article, we are going to take a look at where Compass Therapeutics, Inc. (NASDAQ:CMPX) stands against the other biotech stocks. No matter the market environment, you’ll always find ...

In this article, we are going to take a look at where Compass Therapeutics, Inc. (NASDAQ:CMPX) stands against the other biotech stocks. No matter the market environment, you’ll always find ...

No matter the market environment, you’ll always find entertainment in the biotech space. There will always be biotech stocks making huge swings in both directions and these stocks can make or ...

CMPX stock opened at $2.92 on Tuesday. The company has a market capitalization of $401.76 million, a P/E ratio of -7.89 and a beta of 1.17. Compass Therapeutics has a 12 month low of $0.76 and a ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...